Rafferty Asset Management, LLC Anavex Life Sciences Corp. Transaction History

Rafferty Asset Management, LLC

  • $27.6 Billion
  • Q4 2024

A detailed history of Rafferty Asset Management, LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 74,601 shares of AVXL stock, worth $651,266. This represents 0.0% of its overall portfolio holdings.

Number of Shares
74,601
Previous 139,586 46.56%
Holding current value
$651,266
Previous $792,000 1.14%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$5.11 - $12.56 $332,073 - $816,211
-64,985 Reduced 46.56%
74,601 $801,000
Q3 2024

Nov 13, 2024
SELL
$4.11 - $7.04 $348,232 - $596,485
-84,728 Reduced 37.77%
139,586 $792,000
Q2 2024

Aug 13, 2024
SELL
$3.39 - $5.02 $1.51 Million - $2.24 Million
-445,631 Reduced 66.52%
224,314 $946,000
Q1 2024

May 13, 2024
BUY
$4.55 - $6.75 $1.99 Million - $2.96 Million
437,914 Added 188.73%
669,945 $3.41 Million
Q4 2023

Feb 13, 2024
SELL
$5.04 - $9.95 $195,335 - $385,632
-38,757 Reduced 14.31%
232,031 $2.16 Million
Q3 2023

Nov 13, 2023
SELL
$6.55 - $9.37 $523,174 - $748,419
-79,874 Reduced 22.78%
270,788 $1.77 Million
Q2 2023

Aug 11, 2023
SELL
$7.66 - $9.5 $877,782 - $1.09 Million
-114,593 Reduced 24.63%
350,662 $2.85 Million
Q1 2023

May 11, 2023
BUY
$8.32 - $11.75 $4,168 - $5,886
501 Added 0.11%
465,255 $3.99 Million
Q4 2022

Feb 13, 2023
BUY
$7.65 - $14.43 $1.45 Million - $2.74 Million
189,808 Added 69.03%
464,754 $4.3 Million
Q3 2022

Nov 14, 2022
BUY
$8.9 - $12.86 $953,457 - $1.38 Million
107,130 Added 63.84%
274,946 $2.84 Million
Q2 2022

Aug 12, 2022
SELL
$7.31 - $12.84 $1.46 Million - $2.57 Million
-200,283 Reduced 54.41%
167,816 $1.68 Million
Q1 2022

May 13, 2022
BUY
$9.74 - $17.69 $1.22 Million - $2.21 Million
125,185 Added 51.53%
368,099 $4.53 Million
Q4 2021

Feb 10, 2022
BUY
$16.88 - $23.31 $1.29 Million - $1.78 Million
76,282 Added 45.78%
242,914 $4.21 Million
Q3 2021

Nov 10, 2021
SELL
$16.82 - $25.75 $27,870 - $42,667
-1,657 Reduced 0.98%
166,632 $2.99 Million
Q2 2021

Aug 10, 2021
BUY
$10.16 - $28.86 $501,009 - $1.42 Million
49,312 Added 41.45%
168,289 $3.85 Million
Q1 2021

May 10, 2021
BUY
$5.17 - $16.13 $615,111 - $1.92 Million
118,977 New
118,977 $1.78 Million

Others Institutions Holding AVXL

# of Institutions
188
Shares Held
29.2M
Call Options Held
894K
Put Options Held
821K
View Full List

About ANAVEX LIFE SCIENCES CORP.

AVXL Quotes by TradingView
  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $680M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email